Inspection Record

Exzell Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-08-30 3 findingsComputer system validationMaterial and supplier controlEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The computerized system used to manage product inventory and distribution records to support recalls was not validated.

2Material and supplier control

The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.

3Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-08-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2026-04-23 · Health Canada · 6 findings
Exzell Pharma Inc. company profile — full history Health Canada documents, 2022 Go to Findings search